GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also cause pregnancy complications and harm some users. Weight-loss drugs are ...

Glucagon-like peptide 1 (GLP-1) receptor agonists are transforming the treatment landscape for type 2 diabetes ( T2D) and obesity, in addition to their cardiovascular benefits. These drugs also show ...

The new weight-loss drugs Wegovy and Zepbound are in high demand, and the clamoring will only increase in coming years, experts predict. That's because drugs like these, which rely at least in part on ...

Physical dependency on prescription medications represents a complex medical reality that millions of people face daily, often without fully understanding how their bodies have adapted to require ...

LSD has shown promise for treating conditions like depression, but it might not do much for ADHD. © cybermagician via Shutterstock LSD can do a lot of things, but ...